This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

ReCor, Otsuka win revival of US PTAB proceedings over Medtronic Ireland patent

( March 27, 2025, 19:21 GMT | Official Statement) -- MLex Summary: The US Court of Appeals for the Federal Circuit said the Patent Trial and Appeal Board erred in its analysis of prior art and rejected without substantial evidence the theory advanced by ReCor Medical and its corporate parent, Otsuka Medical Devices Co. for why it would have been obvious to try ultrasound to ablate renal nerves. The court reinstated an inter partes review of Medtronic Ireland's US Patent No. 8,845,629. See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections